Merck & Co. Inc.

94.57
-0.66 (-0.69%)
At close: Mar 11, 2025, 3:59 PM
94.84
0.29%
After-hours: Mar 11, 2025, 08:00 PM EDT

Merck & Co. Inc. Revenue Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014Mar 31, 2014
Animal Health segment Revenue 1.49B 1.48B 1.51B 14.26B 1.46B 1.49B 1.23B 1.37B 1.47B 1.48B 1.26B 1.42B 1.47B 1.42B 1.17B 1.22B 1.1B 1.21B 1.12B 1.12B 1.12B 1.02B 1.04B 1.02B 1.09B 8.92B 9.29B 9.16B 8.76B 8.19B 8.9B 9.44B 8.7B 8.1B 9.03B 8.93B 8.56B 8.27B 9.37B 9.13B 9.09B 8.45B
Animal Health segment Revenue Growth +0.34% -1.92% -89.41% +879.60% -2.35% +21.22% -10.28% -6.54% -1.01% +17.53% -11.01% -3.74% +3.81% +21.40% -4.26% +10.81% -9.31% +8.20% 0.00% -0.18% +9.66% -1.06% +1.47% -6.33% -87.78% -3.99% +1.46% +4.53% +7.01% -8.08% -5.71% +8.54% +7.35% -10.22% +1.14% +4.22% +3.61% -11.78% +2.58% +0.52% +7.53% n/a
Pharmaceutical segment Revenue 14.94B 14.41B 14.01B 1.4B 13.46B 12.72B 12.18B 12.96B 12.76B 14.11B 10.6B 11.5B 9.98B 10.68B 11.37B 11.32B 9.68B 10.65B 10.53B 11.1B 10.46B 9.66B 9.83B 9.66B 9.28B 1.06B n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pharmaceutical segment Revenue Growth +3.71% +2.87% +900.43% -89.60% +5.79% +4.45% -6.05% +1.62% -9.58% +33.05% -7.77% +15.19% -6.51% -6.09% +0.42% +16.95% -9.16% +1.16% -5.07% +6.07% +8.25% -1.70% +1.78% +4.05% +771.55% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Quarter Dec 30, 2023Dec 30, 2022Dec 30, 2021Dec 30, 2020Dec 30, 2019Dec 30, 2018Dec 30, 2017Dec 30, 2016Dec 31, 2015Dec 31, 2014Dec 31, 2013Dec 31, 2012Dec 31, 2011Dec 31, 2010
United States Revenue 28.48B 27.21B 22.43B 21.03B 20.32B 18.21B 17.42B 18.48B 6.49B 7.42B 7.89B 5.1B 4.83B 3.77B
United States Revenue Growth +4.68% +21.32% +6.65% +3.45% +11.60% +4.52% -5.70% +184.58% -12.52% -5.92% +54.63% +5.52% +28.32% n/a
Europe, Middle East And Africa Revenue 13.25B 14.49B 13.34B 13.6B 12.71B 12.21B 11.48B 10.95B 2.82B 3.15B 3.2B n/a n/a n/a
Europe, Middle East And Africa Revenue Growth -8.55% +8.64% -1.90% +7.03% +4.04% +6.40% +4.79% +287.99% -10.41% -1.62% n/a n/a n/a n/a
China Revenue 6.8B 5.19B 4.38B 3.62B 3.58B 3.21B 4.34B 3.92B n/a n/a n/a n/a n/a n/a
China Revenue Growth +31.03% +18.57% +20.81% +1.14% +11.55% -25.94% +10.69% n/a n/a n/a n/a n/a n/a n/a
Asia Pacific Revenue 3.23B 3.63B 2.73B 3.38B 3.21B 2.91B 3.12B 2.85B n/a n/a n/a n/a n/a n/a
Asia Pacific Revenue Growth -11.13% +33.13% -19.25% +5.27% +10.24% -6.82% +9.70% n/a n/a n/a n/a n/a n/a n/a
Japan Revenue 3.16B 3.61B 2.41B 2.86B 2.94B 2.42B 2.34B 2.15B n/a n/a n/a n/a n/a n/a
Japan Revenue Growth -12.45% +50.15% -15.96% -2.68% +21.86% +3.25% +8.54% n/a n/a n/a n/a n/a n/a n/a
Latin America Revenue 3.09B 2.58B 2.21B 2.27B 2.47B 2.18B 1.42B 1.46B n/a n/a n/a n/a n/a n/a
Latin America Revenue Growth +19.52% +17.04% -2.99% -7.90% +13.05% +53.59% -2.40% n/a n/a n/a n/a n/a n/a n/a
Other Revenue 2.1B 2.57B 1.22B 1.23B 1.61B 1.15B n/a n/a n/a n/a n/a n/a n/a n/a
Other Revenue Growth -18.07% +110.32% -0.65% -23.47% +39.77% n/a n/a n/a n/a n/a n/a n/a n/a n/a

Operating Expense Breakdown

Quarter Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 3.3B 2.73B 2.74B 2.48B 2.8B 2.52B 2.7B 2.48B 2.69B 2.52B 2.51B 2.32B 2.83B 2.34B 2.28B 2.19B 3.08B 2.06B 2.08B 2.56B 2.89B 2.59B 2.71B 2.42B 2.64B 2.44B 2.51B 2.51B 2.58B 2.46B 2.5B 2.47B 2.59B 2.39B 2.46B 2.32B 2.62B 2.47B 2.62B 2.6B
Selling, General, and Administrative Revenue Growth +20.69% -0.29% +10.31% -11.45% +11.31% -6.77% +9.00% -7.74% +6.63% +0.32% +8.14% -17.92% +21.15% +2.41% +4.30% -29.11% +49.76% -1.20% -18.40% -11.56% +11.59% -4.54% +11.84% -8.25% +8.19% -2.59% n/a -2.75% +4.88% -1.64% +1.13% -4.67% +8.36% -2.64% +6.04% -11.36% +5.78% -5.79% +0.88% n/a
Research and Development Revenue 4.58B 5.86B 3.5B 3.99B 9.63B 3.31B 13.32B 4.28B 3.77B 4.4B 2.8B 2.58B 3.07B 2.44B 4.32B 2.41B 5.84B 3.35B 2.08B 2.21B 2.55B 3.2B 2.19B 1.93B 2.21B 2.07B 2.27B 3.2B 2.28B 4.41B 1.78B 1.83B 4.65B 1.66B 2.15B 1.66B 1.8B 1.5B 1.67B 1.74B
Research and Development Revenue Growth -21.80% +67.49% -12.32% -58.53% +191.11% -75.17% +211.53% +13.27% -14.19% +57.22% +8.62% -16.04% +25.48% -43.42% +79.15% -58.68% +74.29% +60.62% -5.61% -13.30% -20.47% +46.37% +13.36% -12.78% +7.06% -9.06% -28.85% +40.11% -48.31% +147.64% -2.62% -60.64% +179.39% -22.64% +29.66% -7.73% +19.87% -10.18% -3.86% n/a